Αποτελέσματα Αναζήτησης
8 ώρες πριν · PAVmed Inc. (PAVM) has shown a remarkable revenue growth of 378.63% over the last twelve months as of Q2 2024, with a quarterly spike of 489.76%. This data underlines the company's aggressive expansion in sales, aligning with the significant year-over-year growth reported by its subsidiary, Lucid Diagnostics.
